Article
Therapy for neuromuscular disorders.
Current opinion in genetics & development - 1 Jun 2009
Arnett Andrea L H, Chamberlain Joel R, Chamberlain Jeffrey S
Abstract excerpt
Research into therapeutic approaches for both recessive and dominant neuromuscular disorders has made great progress over the past few years. In the field of gene therapy, antisense-mediated exon skipping is being applied to bypass deleterious mutations in the dystrophin gene and restore dystrophin expression in animal models of muscular dystrophy. Approaches for the dominant genetic muscle diseases have turned...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
